VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by NEWBIEVESTORon Mar 03, 2017 1:54pm

68 Views

Post# 25928390

>>>>>>New Investors Read This<<<<<<<

Here is the link of the CEO speaking about his company in December

https://equity.guru/2016/12/20/podcast-ventripoint-diagnostics-vpt-v-ceo-gets-heart-matter/

Summary:
-VMS Technology is FDA Approved and Health Canada Approved
-25,000 cardiologists in North America
-$75,000 per unit
-Has exposure to China
-CEO believes his company should be at a $50mil-100mil market cap back in DECEMBER before yesterdays NR
-CEO believes his company will be bought out by a bigger company like GE
-There WILL be dilution at some point to fund production and sales of the VMS, unless it gets bought out

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading